Plans by Asian tycoon Li Ka-shing to list his AS Watson health and beauty chain are set to be axed, with Singapore’s Temasek instead poised to invest up to US$6bn for a 25 per cent stake in the business, two people familiar with the matter said.
兩位知情人士表示，屈臣氏(AS Watson)將終止其上市計劃，因爲新加坡的淡馬錫(Temasek)準備投資總計60億美元購買前者25%的股份。屈臣氏是亞洲大亨李嘉誠旗下的健康與美容連鎖店。
您已閱讀24%（340字），剩餘76%（1080字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。